Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Troriluzole in Obsessive Compulsive Disorder
NCT04693351Phase 3Completed
- Sponsor
- Biohaven Ltd.
- Start
- Jan 2021
- Primary completion
- Apr 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands, Peptides
- Countries
- 7
01
Overview
A Phase 3 trial of troriluzole in obsessive compulsive disorder (OCD), sponsored by Biohaven Ltd.. Started Jan 2021; status: completed.
02
Drugs
troriluzole
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04693351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693351.